Viewing Study NCT03445650


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2026-02-20 @ 10:08 PM
Study NCT ID: NCT03445650
Status: COMPLETED
Last Update Posted: 2023-02-09
First Post: 2018-02-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)
Sponsor: Aldeyra Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sjogren-Larsson Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ADX-102, Sjögren-Larsson Syndrome View